Once-Weekly Somapacitan Versus Daily Growth Hormone in Growth Hormone Deficiency: 2-Year Efficacy Results From REAL 3, a Randomized Phase 2 Trial

Category Primary study
JournalJournal of the Endocrine Society
Year 2021
This article has no abstract
Epistemonikos ID: 26d4fc449f42e34cab5eeeb076beeab06320ad78
First added on: Dec 07, 2023